Avantor (AVTR) Net Income towards Common Stockholders (2018 - 2026)

Avantor (AVTR) recorded quarterly Net Income towards Common Stockholders of $43.3 million in Q1 2026, down 17.37% quarter-over-quarter from $52.4 million in Q4 2025, and down 32.87% on a YoY basis from $64.5 million in Q1 2025.

Avantor (AVTR) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

Avantor's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at $43.3 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 32.87% year-over-year to $43.3 million; the TTM figure through Mar 2026 stood at -$551.4 million (down 177.05% YoY), while the FY2025 annual figure was -$530.2 million, down 174.52% from the prior year.
  • Net Income towards Common Stockholders was $43.3 million for Q1 2026 at Avantor, down from $52.4 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $500.4 million in Q4 2024 to a low of -$711.8 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged $71.1 million across 5 years, with a median of $92.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders soared 1372.6% in 2024, then plunged 1331.49% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $141.7 million in 2022, then tumbled by 30.49% to $98.5 million in 2023, then surged by 408.02% to $500.4 million in 2024, then slumped by 89.53% to $52.4 million in 2025, then retreated by 17.37% to $43.3 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $43.3 million (Q1 2026), $52.4 million (Q4 2025), and -$711.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Avantor 6.47 Bn 6.19 Bn 500.70 Mn 43.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 43.30 Mn
Dec 31, 2025 52.40 Mn
Sep 30, 2025 -711.80 Mn
Jun 30, 2025 64.70 Mn
Mar 31, 2025 64.50 Mn
Dec 31, 2024 500.40 Mn
Sep 30, 2024 57.80 Mn
Jun 30, 2024 92.90 Mn
Mar 31, 2024 60.40 Mn
Dec 31, 2023 98.50 Mn
Sep 30, 2023 108.40 Mn
Jun 30, 2023 -7.30 Mn
Mar 31, 2023 121.50 Mn
Dec 31, 2022 141.70 Mn
Sep 30, 2022 167.00 Mn
Jun 30, 2022 179.30 Mn
Mar 31, 2022 174.30 Mn
Dec 31, 2021 77.80 Mn
Sep 30, 2021 140.70 Mn
Jun 30, 2021 141.60 Mn